Growth of generics in Bangladesh and the impact of COVID-19

Chief Operating Officer
Beximco Pharmaceuticals Ltd.

Bangladesh is a growing market with the pharmaceutical industry contributing to nearly 1% of the GDP. With over 200 local companies, most of which have experience exporting to the RoW markets and a section focusing on the regulated markets like US and EU, the industry is ready to move towards the next phase of growth.

Join this webinar to hear from our guest speaker Mr. Rabbur Reza, Chief Operating officer at Beximco Pharmaecuticals to understand the latest trends from the Bangladesh market and its significance for the pharmaceutical industry, the factors that will drive future growth, partnership opportunities with India, the changes the market has undergone as a result of the pandemic and how insightful intelligence from Clarivate can help organizations with global growth ambitions in the generics market.